Decode Genetics' Stock to be Suspended on Nasdaq Tomorrow | GenomeWeb

NEW YORK (GenomeWeb News) – Decode Genetics has received notification from the Nasdaq Stock Market that the firm's common stock will be suspended from trading as of the open of business tomorrow.

The Iceland-based firm also said that documents will be filed with the US Securities and Exchange Commission, which will remove the firm's common stock from listing on Nasdaq.

Decode said that it is possible its stock will be traded thereafter on the Pink Sheets, but that depends if there is a market maker for the shares.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.